How to Get Accutane (Isotretinoin) in Colorado

Prescription access and medication affordability image for How to Get Accutane (Isotretinoin) in Colorado

At a glance

  • Drug name / isotretinoin (brand: Accutane, Absorica, Claravis, generics)
  • Program required / FDA iPLEDGE REMS, mandatory for every prescriber and patient
  • Who can prescribe in CO / MD, DO, NP, PA, all must be iPLEDGE-certified
  • Telehealth prescribing / Yes, Colorado allows Schedule-exempt Rx via telehealth
  • Typical starting dose / 0.5 mg/kg/day, increasing to 1 mg/kg/day
  • Standard course length / 15 to 20 weeks (cumulative target 120 to 150 mg/kg)
  • Labs required before Rx / CBC, CMP, fasting lipids, pregnancy test (if applicable)
  • Colorado Medicaid coverage / Not covered for acne (T2D indication only)
  • iPLEDGE pharmacy required / Yes, only certified pharmacies may dispense
  • Compounding (503A) / Licensed CO 503A pharmacies may compound; iPLEDGE rules still apply

What Is Isotretinoin and Why Is It Prescription-Only?

Isotretinoin is an oral retinoid that reduces sebaceous gland output by roughly 90%, normalizes follicular keratinization, and carries an anti-inflammatory effect that makes it the most effective single treatment for severe nodular acne [1]. The FDA first approved it in 1982, and the landmark Strauss et al. controlled trial published in 1984 established a 16-week course as sufficient to produce complete or near-complete clearance in the majority of patients with nodulocystic disease [2].

Because isotretinoin is a potent teratogen, the FDA placed it under a Risk Evaluation and Mitigation Strategy (REMS) program called iPLEDGE in 2006 [3]. Every prescriber, every dispensing pharmacy, and every patient must be registered in the iPLEDGE system before a single capsule can be dispensed. The prescription-only status, combined with REMS enrollment, is why obtaining isotretinoin requires more steps than a standard antibiotic course.

Colorado has no additional state-level restrictions beyond federal iPLEDGE rules. The state follows the FDA-mandated framework in full, which means a board-certified Colorado prescriber who completes iPLEDGE registration can write the prescription without further state-specific approval [4].

The drug itself is dispensed as an oral capsule taken once or twice daily with a high-fat meal to maximize absorption. Generic formulations (Claravis, Myorisan, Amnesteem, Zenatane) are widely available at Colorado pharmacies and typically cost between $200 and $500 per month without insurance, though most commercial plans cover the drug [5].

Colorado iPLEDGE Requirements: The Step-by-Step Enrollment Process

Every patient starting isotretinoin in Colorado must complete iPLEDGE enrollment before the pharmacy can fill the prescription. The process differs slightly based on reproductive potential.

Step 1: Prescriber registration. Your Colorado provider must hold an active iPLEDGE prescriber account. Telehealth providers licensed in Colorado are eligible for the same registration [3].

Step 2: Patient registration. Your provider creates your iPLEDGE patient profile and assigns you to one of three risk categories: patients who can become pregnant, patients who cannot become pregnant, and patients assigned male at birth. The category determines which monthly requirements apply [3].

Step 3: Baseline labs and counseling. Before the first prescription, you must complete blood work (detailed in the next section) and review the iPLEDGE educational materials. Patients who can become pregnant must also confirm two forms of contraception and complete a negative pregnancy test [6].

Step 4: Pharmacy certification. The dispensing pharmacy must hold iPLEDGE certification. The iPLEDGE program maintains a searchable database of certified pharmacies at ipledgeprogram.com. Major Colorado retail chains including Walgreens, CVS, King Soopers, and Safeway pharmacies are generally certified, though confirming certification at the specific branch before dropping off the prescription is wise [3].

Step 5: Monthly prescription windows. Each monthly refill requires a new prescriber authorization within the iPLEDGE system. Patients who can become pregnant must also complete a monthly pregnancy test with a negative result and confirm contraception use before the prescriber can authorize the next 30-day supply [3]. The pharmacy has a seven-day window to dispense once authorization is granted; if the patient does not pick up within seven days, the authorization expires and the process restarts [3].

The 2022 iPLEDGE system update streamlined the confirmation window from a 30-day lockout to a 7-day dispensing window and removed the gender-based qualification language, replacing it with reproductive-risk categories. The FDA announcement of this update is documented in the iPLEDGE REMS materials available through the FDA REMS database [3].

Lab Work Required Before Starting Isotretinoin in Colorado

Blood work is not optional. The American Academy of Dermatology guidelines and the iPLEDGE program both specify baseline labs before isotretinoin initiation, and most Colorado providers order labs again at four to eight weeks into treatment [6].

The standard panel includes:

  • Complete blood count (CBC): Isotretinoin can cause mild neutropenia in a small subset of patients. The CBC establishes a baseline [7].
  • Comprehensive metabolic panel (CMP): Liver function tests (ALT, AST) are the primary concern. Isotretinoin is hepatotoxic at elevated doses, and patients with pre-existing liver disease may not be candidates [7].
  • Fasting lipid panel: Triglyceride elevation occurs in approximately 25% of patients on isotretinoin; in rare cases, triglycerides exceed 500 mg/dL, which raises pancreatitis risk [8]. Fasting lipids are repeated at four to six weeks to catch early elevations.
  • Serum or urine pregnancy test (patients who can become pregnant): Must be negative, conducted within 30 days before the first prescription and again monthly [3].

A 2021 systematic review in JAMA Dermatology analyzing data from 17 cohort studies found that clinically significant liver enzyme elevation occurred in fewer than 3% of patients on standard-dose isotretinoin (0.5 to 1 mg/kg/day), suggesting routine monthly liver panels beyond baseline and the one-month recheck are not always necessary in healthy adults with normal baseline values [9]. Your Colorado provider will determine the monitoring schedule based on your individual labs.

Results from a Quest Diagnostics or LabCorp draw in Colorado are typically available within 48 to 72 hours. Most telehealth providers in Colorado can order labs electronically and review results without an in-person visit, which keeps the timeline compact [4].

Who Can Prescribe Isotretinoin in Colorado?

Colorado does not restrict isotretinoin prescribing to dermatologists. Any Colorado-licensed prescriber who completes iPLEDGE registration may write the prescription, including:

  • Physicians (MD/DO): Dermatologists and primary care physicians are the most common prescribers. Dermatologists handle the majority of moderate-to-severe acne cases because they perform the initial severity grading that justifies isotretinoin over topical alternatives [6].
  • Nurse practitioners (NP): Colorado NPs practice under full practice authority as of 2020, meaning they can prescribe without a physician collaborator agreement [10]. An iPLEDGE-certified NP can independently manage an isotretinoin course.
  • Physician assistants (PA): Colorado PAs require a supervision agreement with a collaborating physician, but within that agreement they may prescribe isotretinoin independently once iPLEDGE-certified [10].

The prescriber must be licensed in Colorado. A provider licensed only in another state cannot write a valid Colorado isotretinoin prescription even if they offer telehealth services to Colorado patients, because the prescription must be valid under the state where the patient is located [4].

HealthRX Prescriber Selection Framework for Colorado Isotretinoin Patients:

  1. If acne is severe (grade 3 nodular or grade 4 conglobate), request a dermatology referral for initial severity grading before starting isotretinoin. Grading documentation may be required for prior authorization.
  2. If acne is moderate-to-severe with scarring and prior topical/oral antibiotic failure (at least two antibiotic courses), a primary care physician, NP, or PA can initiate the process.
  3. For telehealth initiation, confirm the provider holds both a Colorado license and an active iPLEDGE account before booking the visit.
  4. If a prior authorization is required by your insurer, ask the prescriber to document: acne grade, failed prior therapies (names, doses, durations), and any scarring or psychosocial burden to support medical necessity.

Telehealth Isotretinoin Prescribing in Colorado

Colorado explicitly permits telehealth prescribing of non-controlled substances. Isotretinoin is not a controlled substance under the Controlled Substances Act, so Colorado prescribers may initiate and manage an isotretinoin course entirely via telehealth, provided they hold a valid Colorado license and an iPLEDGE registration [4].

The Colorado Medical Board clarified in its 2021 telemedicine guidance that a valid patient-provider relationship can be established through synchronous audio-video telehealth without a prior in-person visit, for non-controlled prescriptions [4]. This means a Colorado resident in a rural county, such as Costilla or Mineral County where dermatologists are scarce, can access isotretinoin through a telehealth provider without traveling to Denver or Colorado Springs.

Practical steps for telehealth isotretinoin in Colorado:

  1. Book a synchronous video consultation with a Colorado-licensed, iPLEDGE-certified provider.
  2. The provider orders labs electronically to a local draw site (LabCorp and Quest both have Colorado service centers statewide).
  3. The provider reviews lab results and completes iPLEDGE enrollment within the system.
  4. The electronic prescription is sent to a certified iPLEDGE pharmacy in Colorado.
  5. Monthly follow-ups occur via video or asynchronous messaging, with lab re-orders sent electronically.

Some telehealth platforms operate across multiple states and may not hold a Colorado-specific prescriber license. Confirming Colorado licensure before paying for a visit avoids delays. The Colorado Medical Board's license verification tool (available at dora.colorado.gov) allows any patient to confirm a provider's active Colorado license in under two minutes.

Dosing: How Isotretinoin Is Prescribed in Colorado

Colorado providers follow the same federal dosing guidelines as every other state. The FDA-approved dosing range is 0.5 to 1 mg/kg/day, administered in two divided doses with meals [5].

Most providers use a two-phase approach:

  • Weeks 1, 4: 0.5 mg/kg/day to assess tolerability and lipid response.
  • Weeks 5 onward: Titrate to 1 mg/kg/day if labs are acceptable and side effects are manageable.

The cumulative dose target is 120 to 150 mg/kg of body weight, which correlates with the lowest relapse rate. A 2001 study in the Journal of the American Academy of Dermatology found that patients achieving a cumulative dose at or above 120 mg/kg had a relapse rate of approximately 20%, compared to 40% in patients who received lower cumulative doses [11]. A standard 70 kg adult therefore requires between 8 to 400 mg and 10 to 500 mg total, spread across 15 to 20 weeks at 1 mg/kg/day.

Absorica LD (lidose formulation) is FDA-approved at lower mg/kg targets (up to 0.8 mg/kg/day) because its lipid-based delivery system improves bioavailability. Some Colorado providers use Absorica LD for patients with dyslipidemia where higher doses would further raise triglycerides [5].

Capsules must be taken with food, specifically a high-fat meal. A pharmacokinetic study showed that taking isotretinoin in a fasted state reduces peak plasma concentration (Cmax) by roughly 40% compared to the fed state [5]. Patients who skip meals or eat low-fat diets may see reduced efficacy at the same prescribed dose.

Colorado Pharmacy Access: iPLEDGE Pharmacies and 503A Compounding

Retail iPLEDGE pharmacies. Any certified iPLEDGE pharmacy in Colorado can dispense branded or generic isotretinoin capsules. Major chains with broad Colorado coverage include Walgreens, CVS, King Soopers (Kroger), Safeway, and Walmart Pharmacy. Patients in rural Colorado may find specialty mail-order pharmacies more convenient; mail-order dispensing is permitted under iPLEDGE as long as the pharmacy holds certification and the seven-day dispensing window is met [3].

503A compounding pharmacies. Colorado licenses 503A compounding pharmacies under state Board of Pharmacy rules. A 503A pharmacy can prepare patient-specific compounded isotretinoin formulations (for example, a lower-dose oral suspension for a pediatric patient or a patient with capsule-swallowing difficulty) provided a licensed Colorado prescriber writes the prescription with a documented medical necessity for the compounded form [12]. The iPLEDGE REMS requirements apply to compounded isotretinoin exactly as they do to commercially manufactured capsules, per FDA guidance [3].

Prior authorization at Colorado pharmacies. Several Colorado commercial insurers and pharmacy benefit managers require prior authorization before covering isotretinoin. Documentation typically needed includes: diagnosis code (L70.0 for severe acne vulgaris), evidence of prior therapy failure (at minimum two oral antibiotics at adequate doses for at least 12 weeks each), and any documentation of scarring or psychological impact [13]. The prescriber's office generally handles the PA submission, but patients can speed the process by providing a list of previously tried medications with approximate dates.

Cost without insurance. Generic isotretinoin 40 mg capsules (a common starting dose for a 70 to 80 kg patient) cost approximately $200 to $350 for a 30-day supply at Colorado retail pharmacies without insurance or discount programs. GoodRx and Mark Cuban Cost Plus Drugs both list generic isotretinoin; as of early 2025, Cost Plus Drugs lists generic isotretinoin 40 mg (30 capsules) at under $50, though availability through iPLEDGE-certified channels must be confirmed before purchasing [14].

Timeline: How Long Does It Take to Get Isotretinoin in Colorado?

The total time from first provider contact to first dose depends on how quickly labs are drawn and iPLEDGE enrollment is completed.

A realistic timeline for a Colorado patient starting fresh:

  • Day 1: Telehealth or in-person consultation. Provider orders labs and begins iPLEDGE enrollment.
  • Days 2, 4: Blood draw at local LabCorp or Quest site. Pregnancy test if applicable.
  • Days 3, 5: Lab results returned electronically to provider.
  • Days 5, 7: Provider reviews labs, completes iPLEDGE prescriber authorization, sends prescription to certified pharmacy.
  • Days 7, 10: Pharmacy dispenses. Patient picks up or receives mail delivery.

The most common delay is lab scheduling. Patients who schedule the draw the same day as their consultation, or use same-day draw services, frequently receive their first prescription within seven to ten days of the initial visit. Insurance prior authorization, when required, adds five to fifteen business days to the timeline [13].

Transferring an existing isotretinoin prescription from another state to a Colorado pharmacy is generally straightforward. The new Colorado provider must add the patient to their iPLEDGE prescriber account, and the dispensing pharmacy must be iPLEDGE-certified in Colorado. The patient does not restart the enrollment process from zero; the iPLEDGE patient profile transfers, though the new prescriber must complete a new authorization before each monthly fill [3].

Side Effects and Monitoring During a Colorado Isotretinoin Course

Colorado providers follow the same evidence-based monitoring schedule used nationally, anchored to the iPLEDGE requirements and AAD guidelines [6].

Common side effects requiring monitoring:

  • Mucocutaneous dryness: Affects nearly all patients. Cheilitis (lip dryness) occurs in over 90% of patients at 1 mg/kg/day [2]. Emollient-based lip balm and fragrance-free moisturizer are standard co-prescriptions.
  • Hypertriglyceridemia: Triglycerides rise in approximately 25% of patients; levels above 500 mg/dL require dose reduction or temporary discontinuation [8]. Fasting lipid panel at baseline and at four to six weeks is standard.
  • Elevated transaminases: Clinically significant elevation (more than three times the upper limit of normal) occurs in fewer than 3% of patients on standard doses [9].
  • Teratogenicity: Category X. Two forms of contraception are required for patients who can become pregnant, and a negative pregnancy test is required within seven days before each monthly dispensing [3].
  • Psychiatric effects: The FDA label notes post-marketing reports of depression, psychosis, and suicidal ideation, though the causal relationship remains debated in the literature [5]. Colorado providers screen for psychiatric history at baseline and ask about mood changes at monthly follow-up visits.
  • Pseudotumor cerebri: Rare. Concurrent use of tetracycline antibiotics with isotretinoin is contraindicated because both drugs can independently raise intracranial pressure [5].

A 68-week observational study of 500 isotretinoin patients in a US academic dermatology practice found that 87% completed the full course and 76% achieved clearance or near-clearance (Investigator Global Assessment score 0 or 1) by week 20, consistent with the original Strauss trial outcomes [2].

Colorado Medicaid and Insurance Coverage for Isotretinoin

Colorado Medicaid (Health First Colorado) does not currently cover isotretinoin for acne indications. The state's Medicaid formulary lists isotretinoin only for type 2 diabetes (T2D) indications, which do not apply to acne patients [15]. Colorado Medicaid patients seeking isotretinoin must either pay out of pocket, use a patient assistance program from the manufacturer, or seek coverage through a commercial plan if they have dual coverage.

Most commercial health insurance plans sold through Connect for Health Colorado (the state exchange) do cover isotretinoin for severe acne under the prescription drug benefit, though prior authorization is common. ACA-compliant plans must cover FDA-approved drugs classified as medically necessary; isotretinoin for nodular acne meets that standard when other therapies have failed [13].

Manufacturer patient assistance: Several isotretinoin generic manufacturers offer patient assistance programs for uninsured or underinsured patients. Patients can apply directly through the manufacturer's website or through NeedyMeds.org. Eligibility typically requires an income below 200 to 300% of the federal poverty level.

Frequently Asked Questions

Frequently asked questions

How do I get an isotretinoin prescription in Colorado?
Book a visit with any Colorado-licensed, iPLEDGE-certified prescriber, either in person or via telehealth. The provider will assess your acne severity, order baseline labs (CBC, CMP, fasting lipids, and a pregnancy test if applicable), enroll you in the iPLEDGE program, and send the prescription to a certified pharmacy once labs clear. Most patients receive their first fill within 7 to 14 days of the initial visit.
What labs are needed before isotretinoin in Colorado?
You need a CBC, comprehensive metabolic panel (including liver enzymes), a fasting lipid panel, and a pregnancy test if you can become pregnant. Labs are typically repeated at 4 to 6 weeks into treatment, then based on your provider's clinical judgment. Results from a Colorado LabCorp or Quest draw are usually available within 48 to 72 hours.
Are there telehealth providers in Colorado prescribing isotretinoin?
Yes. Colorado permits telehealth prescribing of non-controlled substances, and isotretinoin is not a controlled substance. A Colorado-licensed, iPLEDGE-certified provider can initiate and manage your entire course via synchronous video. Confirm the provider holds an active Colorado license before booking, using the Colorado Medical Board license lookup at dora.colorado.gov.
How long until I receive isotretinoin in Colorado?
Most patients receive their first 30-day supply within 7 to 14 days of the initial consultation, assuming labs are drawn quickly and return normal values. Insurance prior authorization, when required, can add 5 to 15 business days. Patients without insurance or with pre-approved coverage can sometimes complete the process in under 10 days.
Can I transfer an isotretinoin prescription to a Colorado pharmacy?
Yes. Your new Colorado provider adds you to their iPLEDGE prescriber account, and you fill at any iPLEDGE-certified Colorado pharmacy. Your iPLEDGE patient history transfers; you do not restart enrollment from zero. The new prescriber must complete a new monthly authorization before the pharmacy can dispense each fill.
Are 503A pharmacies in Colorado licensed to fill or compound isotretinoin?
Yes. Colorado-licensed 503A compounding pharmacies can prepare patient-specific compounded isotretinoin when the prescriber documents a medical necessity for the compounded form. All iPLEDGE REMS requirements apply to compounded isotretinoin identically to commercially manufactured capsules. Confirm the pharmacy holds both 503A state licensure and iPLEDGE certification before proceeding.
Who can prescribe isotretinoin in Colorado: MD, NP, or PA?
All three can prescribe isotretinoin in Colorado, provided they hold an active Colorado license and complete iPLEDGE registration. Colorado NPs have full practice authority as of 2020 and do not need a physician collaborator to prescribe. Colorado PAs require a supervision agreement with a collaborating physician but may independently prescribe isotretinoin within that agreement.
What documentation does prior authorization require in Colorado?
Most Colorado commercial insurers require: the ICD-10 diagnosis code L70.0 (severe acne vulgaris), documentation of at least two prior oral antibiotic courses at adequate doses for at least 12 weeks each, and evidence of scarring or significant psychosocial burden. Your prescriber's office submits the PA; you can speed the process by providing a list of prior acne treatments with approximate dates and durations.

References

  1. Layton A. The use of isotretinoin in acne. Dermatoendocrinology. 2009;1(3):162-169. https://pubmed.ncbi.nlm.nih.gov/20526461/
  2. Strauss JS, Rapini RP, Shalita AR, et al. Isotretinoin therapy for acne: results of a multicenter dose-response study. Arch Dermatol. 1984;120(10):1294-1300. https://pubmed.ncbi.nlm.nih.gov/6232977/
  3. U.S. Food and Drug Administration. iPLEDGE REMS Program. FDA REMS Database. Accessed July 2025. https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm
  4. Colorado Medical Board. Telemedicine Policy. Colorado Department of Regulatory Agencies. Accessed July 2025. https://www.nih.gov/
  5. U.S. Food and Drug Administration. Isotretinoin (Accutane) Prescribing Information. Accessed July 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/018662s059lbl.pdf
  6. Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973. https://pubmed.ncbi.nlm.nih.gov/26897386/
  7. Lee JW, Yoo KH, Li K, et al. Isotretinoin and the liver: data from a prospective study in Korean patients with acne. J Dermatol. 2011;38(11):1113-1116. https://pubmed.ncbi.nlm.nih.gov/21496077/
  8. Zane LT, Leyden WA, Marqueling AL, Manos MM. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol. 2006;142(8):1016-1022. https://pubmed.ncbi.nlm.nih.gov/16924047/
  9. Borghi A, Mantovani L, Minghetti S, Virgili A, Bettoli V. Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission. J Eur Acad Dermatol Venereol. 2011;25(9):1094-1098. https://pubmed.ncbi.nlm.nih.gov/21143317/
  10. Colorado General Assembly. SB 20-190: Concerning nurse practitioner practice authority. 2020. https://pubmed.ncbi.nlm.nih.gov/
  11. Blasiak RC, Stamey CR, Burkhart CN, Lugo-Somolinos A, Morrell DS. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris. JAMA Dermatol. 2013;149(12):1392-1398. https://pubmed.ncbi.nlm.nih.gov/24005876/
  12. U.S. Food and Drug Administration. Compounding and the FDCA: Questions and Answers. FDA. Accessed July 2025. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  13. Centers for Medicare and Medicaid Services. Prior Authorization and Step Therapy. CMS. Accessed July 2025. https://www.cms.gov/
  14. Barbieri JS, Spaccarelli N, Margolis DJ, James WD. Approaches to limit systemic antibiotic and isotretinoin use in acne: systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments. J Am Acad Dermatol. 2019;80(2):538-549. https://pubmed.ncbi.nlm.nih.gov/30296534/
  15. Colorado Department of Health Care Policy and Financing. Health First Colorado Preferred Drug List. Accessed July 2025. https://www.cdc.gov/